Rising prevalence of infectious diseases and growing demand for blood donations are driving the growth of the blood screening market. Additionally, increasing healthcare spending, technological advancements in blood screening techniques, and expanding awareness about the importance of early disease detection are contributing to market growth.
Industry
Report Coverage | Details |
---|---|
Segments Covered | Product, Technology, End-Use |
Regions Covered | • North America (United States, Canada, Mexico) • Europe (Germany, United Kingdom, France, Italy, Spain, Rest of Europe) • Asia Pacific (China, Japan, South Korea, Singapore, India, Australia, Rest of APAC) • Latin America (Argentina, Brazil, Rest of South America) • Middle East & Africa (GCC, South Africa, Rest of MEA) |
Company Profiled | Abbott Laboratories, F. Hoffmann-La Roche., Grifols, S.A., Hologic,, QIAGEN N.V., Becton, Dickinson and Company, Bio-Rad Laboratories,, Siemens Healthineers AG, Thermo Fisher Scientific,, SOFINA s.a (Biomerieux), Danaher, Ortho-Clinical Diagnostics,, DiaSorin S.p.A. |
The stringent regulations and high cost associated with blood screening tests are major restraints hindering market growth. Moreover, shortage of skilled professionals in the field of blood screening is also impacting market expansion.